Arrivent BioPharma, Inc. Presents the Final Analysis of Firmonertinib Monotherapy Data from ...

Retrieved on: 2025-09-09 17:10:19

Tags for this article:

Click the tags to see associated articles and topics

Arrivent BioPharma, Inc. Presents the Final Analysis of Firmonertinib Monotherapy Data from .... View article details on hiswai:

Excerpt

Arrivent BioPharma, Inc. presented positive final proof-of-concept data from the randomized global Phase 1b FURTHER trial for first-line ...

Article found on: www.marketscreener.com